CLASS II Drug recall · Reported 2 Sep 2015 · FDA Enforcement Report

Bactroban Cream (mupirocin calcium), 2%, a) tube recalled

GlaxoSmithKline is recalling Bactroban Cream (mupirocin calcium), 2%, a) tube (, distributed nationwide in the US. The recall was initiated on 13 Aug 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes15 g: Lot #: C695549, Exp 03/2016; 30 g: Lot #: C707836, Exp 7/2016; C718209, Exp 9/2016, Expanded to include: C707837, Exp. 07/2016, C718210, Exp. 09/2016.
Quantity recalled28,480 tubes of 15g, 12,234 tubes of 30g

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1361-2015
FDA event ID
71920
Recalling firm
GlaxoSmithKline, Zebulon, NC
Classification
Class II
Status
Terminated
Recall initiated
13 Aug 2015
FDA classified
25 Aug 2015
Reported
2 Sep 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

13 Aug 2015Recall initiated by company
25 Aug 2015Classified by FDA+12 days
2 Sep 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.

Product as listed by the FDA

Bactroban Cream (mupirocin calcium), 2%, a) 15g tube ( NDC 0029-1527-22), b) 30g tube (NDC 0029-1527-25), Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217.

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.

Which lots are affected?

15 g: Lot #: C695549, Exp 03/2016; 30 g: Lot #: C707836, Exp 7/2016; C718209, Exp 9/2016, Expanded to include: C707837, Exp. 07/2016, C718210, Exp. 09/2016.

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 71920

This product is part of a recall event; the main page for the event is Bactroban Ointment (mupirocin calcium), 2% tube recalled.

More recalls from GlaxoSmithKline

All 23

Other Bactroban (mupirocin recalls

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIBactroban (mupirocin calcium) Nasal Ointment, 2% tube recalledGlaxoSmithKlineOtherNationwide
DrugCLASS IIBactroban Ointment (mupirocin calcium), 2% tube recalledGlaxoSmithKlineOtherNationwide